November 4, 2026 · The American journal of psychiatry · DOI: 10.1176/appi.ajp.20251354

Targeted Use of Kudzu for Binge Drinking Among Adults With Alcohol Use Disorder: A Phase 2b Randomized Trial.

Listen to this summary

This phase 2b double-blind, placebo-controlled trial asked whether as-needed kudzu extract (2 g taken on anticipated binge-drinking days), combined with weekly counseling, reduces binge drinking in adults with alcohol use disorder. Among 120 randomized participants, kudzu reduced binge-drinking days compared with placebo (IRR=0.73 intention-to-treat; IRR=0.58 among those who took it at least 2.7 days per week), with reductions persisting at 3-month follow-up and no serious kudzu-related adverse events. The authors conclude that targeted kudzu use may be a helpful pharmacologic option for binge drinking in AUD.

Glenn-Milo Santos, Phillip Coffin, Allie Dunham, Thomas Hoffmann, John Walker, Tim Matheson, Steven Batki

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play